Prevymis (letermovir) - Merck (MSD)
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis. (PubMed, Open Forum Infect Dis) - May 5, 2025 - P | "Clinical Trials Registration. NCT04412811." 
Journal • Acute Graft versus Host Disease • Bone Marrow Transplantation • Cytomegalovirus Infection • Epstein-Barr Virus Infections • Graft versus Host Disease • Hematological Malignancies • Immunology • Infectious Disease • Leukemia • Oncology • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40322267
 
Adriana Vacca; Alessandra Carotti; Alessandra Picardi; Alessandro Busca; Alfonso Piciocchi; Amelia Rinaldi; Angelo Michele Carella; Anna Paola Iori; Corrado Girmenia; Elisabetta Terruzzi; Fabio Ciceri; Fausto Baldanti; Federica Galaverna; Francesca Bonifazi; Francesco Onida; Gaetana Porto; Giovanni Marsili; Ilaria Cutini; Irene Maria Cavattoni; Luca Castagna; Maria Caterina Micò; Massimo Martino; Maura Faraci; Michele Malagola; Patrizia Chiusolo; Pierangelo Clerici; Raffaella Greco; Roberto Bono; Stefania Bramanti; Tiziana Lazzarotto
 
May 5, 2025
 
Prev Next